Neumora Therapeutics (NMRA) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free NMRA Stock Alerts $9.08 -0.69 (-7.06%) (As of 11:16 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Neumora Therapeutics Short Interest DataCurrent Short Volume6,580,000 sharesPrevious Short Volume5,870,000 sharesChange Vs. Previous Month+12.10%Dollar Volume Sold Short$59.81 millionShort Interest Ratio / Days to Cover11.2Last Record DateApril 30, 2024Outstanding Shares159,450,000 sharesFloat Size53,620,000 sharesShort Percent of Float12.27%Today's Trading Volume50,721 sharesAverage Trading Volume475,452 sharesToday's Volume Vs. Average11% Short Selling Neumora Therapeutics ? Sign up to receive the latest short interest report for Neumora Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNMRA Short Interest Over TimeNMRA Days to Cover Over TimeNMRA Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Neumora Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,580,000 shares $59.81 million +12.1%12.3%11.2 $9.09 4/15/20245,870,000 shares $65.69 million +19.3%11.1%11.1 $11.19 3/31/20244,920,000 shares $67.65 million -2.2%10.1%10.8 $13.75 3/15/20245,030,000 shares $75.90 million +2.7%10.3%12.5 $15.09 2/29/20244,900,000 shares $86.39 million -2.0%10.1%17.1 $17.63 2/15/20245,000,000 shares $94.05 million +11.1%10.7%17.9 $18.81 1/31/20244,500,000 shares $67.05 million No Change9.3%16.7 $14.90 NMRA Short Interest - Frequently Asked Questions What is Neumora Therapeutics' current short interest? Short interest is the volume of Neumora Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 5,870,000 shares of NMRA short. 11.07% of Neumora Therapeutics' shares are currently sold short. Learn More on Neumora Therapeutics' current short interest. What is a good short interest ratio for Neumora Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMRA shares currently have a short interest ratio of 11.0. Learn More on Neumora Therapeutics's short interest ratio. What is a good short interest percentage for Neumora Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.07% of Neumora Therapeutics' floating shares are currently sold short. Is Neumora Therapeutics' short interest increasing or decreasing? Neumora Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 5,870,000 shares, an increase of 19.3% from the previous total of 4,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neumora Therapeutics' float size? Neumora Therapeutics currently has issued a total of 159,450,000 shares. Some of Neumora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neumora Therapeutics currently has a public float of 53,020,000 shares. How does Neumora Therapeutics' short interest compare to its competitors? 11.07% of Neumora Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Neumora Therapeutics: ADMA Biologics, Inc. (3.55%), 4D Molecular Therapeutics, Inc. (19.21%), Tarsus Pharmaceuticals, Inc. (20.91%), Vir Biotechnology, Inc. (5.79%), Scholar Rock Holding Co. (15.91%), Cullinan Oncology, Inc. (6.38%), Inhibrx, Inc. (6.18%), Fusion Pharmaceuticals Inc. (5.73%), Autolus Therapeutics plc (1.53%), Twist Bioscience Co. (21.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Neumora Therapeutics stock? Short selling NMRA is an investing strategy that aims to generate trading profit from Neumora Therapeutics as its price is falling. NMRA shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neumora Therapeutics? A short squeeze for Neumora Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NMRA, which in turn drives the price of the stock up even further. How often is Neumora Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMRA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ADMA Biologics Short Interest Data 4D Molecular Therapeutics Short Interest Data Tarsus Pharmaceuticals Short Interest Data Vir Biotechnology Short Interest Data Scholar Rock Short Interest Data Cullinan Oncology Short Interest Data Inhibrx Short Interest Data Fusion Pharmaceuticals Short Interest Data Autolus Therapeutics Short Interest Data Twist Bioscience Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NMRA) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group